Thaigarajan Parumasivam

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Multidrug Resistant

General Practice

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Zhengrui Liao, Yu-Kee Yeoh, Thaigarajan Parumasivam, Wee Yin Koh, Mohammad Alrosan, Muhammad H Alu'datt, Thuan-Chew Tan
Medium-chain dicarboxylic acids: chemistry, pharmacological properties, and applications in modern pharmaceutical and cosmetics industries. RSC advances 14 (24) (2024)
Zhengrui Liao, Yu-Kee Yeoh, Thaigarajan Parumasivam, Wee Yin Koh, Mohammad Alrosan, Muhammad H Alu'datt, Thuan-Chew Tan
Medium-chain dicarboxylic acids: chemistry, pharmacological properties, and applications in modern pharmaceutical and cosmetics industries. RSC advances 14 (24) (2024)
Priyanka Prakash, Wing-Hin Lee, Ching-Yee Loo, Hau Seung Jeremy Wong, Thaigarajan Parumasivam
Advances in Polyhydroxyalkanoate Nanocarriers for Effective Drug Delivery: An Overview and Challenges. Nanomaterials (Basel, Switzerland) 12 (1) (2022)
Subashini Raman, Vikneswaran Murugaiyah, Thaigarajan Parumasivam
Andrographis paniculata Dosage Forms and Advances in Nanoparticulate Delivery Systems: An Overview. Molecules (Basel, Switzerland) 27 (19) (2022)
Thiruchelvi Pulingam, Jimmy Nelson Appaturi, Thaigarajan Parumasivam, Azura Ahmad, Kumar Sudesh
Biomedical Applications of Polyhydroxyalkanoate in Tissue Engineering. Polymers 14 (11) (2022)
Noratiqah Mohtar, Thaigarajan Parumasivam, Amirah Mohd Gazzali, Chu Shan Tan, Mei Lan Tan, Rozana Othman, Siti Sarah Fazalul Rahiman, Habibah Abdul Wahab
Advanced Nanoparticle-Based Drug Delivery Systems and Their Cellular Evaluation for Non-Small Cell Lung Cancer Treatment. Cancers 13 (14) (2021)
Ibrahim M Abdulbaqi, Reem Abou Assi, Anan Yaghmur, Yusrida Darwis, Noratiqah Mohtar, Thaigarajan Parumasivam, Fadi G Saqallah, Habibah Abdul Wahab
Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)